Upcoming Events

• May 8, 2008
  Using Gamma Scintigraphy to Achieve Optimal Oral Drug Delivery in Early Drug Development
  John McDermott, Pharmaceutical Profiles
  Forum Information
  
  

Useful Links

PDE, A Pharmaceutical Trade Association
http://www.pdetrade.org/

Previous Events

• April 10, 2008
  Tablet Film Coating and the Application of "Quality by Design" Initiatives
  Dr. Stuart C. Porter, International Specialty Products (ISP)
  
  
• March 13th, 2008
  Lipid Based Drug Delivery Systems and Enhanced Bioavailability Mechanisms and Potential
  Dr. Paul M. Bummer , College of Pharmacy, University of Kentucky
  
  
• February 14, 2008
  Next Generation Drug-device Combination Products
  Dr. Jonathon Zhao, Cordis Corporation, A Johnson and Johnson Company
  
  
• January 10, 2008
  Pharmacogenomics: a new approach to drug discovery and treatment
  Dr. Evgeny Krynetskiy, Temple University and the Jayne Haines Center for Pharmacogenomics and Drug Safety
  
  

• November 8, 2007
  Technology Transfer by Design: Using Lean Six Sigma and Quality by Design to Improve the Process
  Ronald D. Snee and William J. Reilly, Jr., Tunnell Consulting

• October 11, 2007
  Nanosizing for Oral Drug Delivery – Biopharmaceutical and Formulation Aspects
  Dr. Filippos Kesisoglou and Dr. Sunny Panmai, Merck Research Laboratories

• September 13, 2007
  Lipid Based Self Micro-Emulsifying Systems (SMEDDS): Applications, Excipient Selection, Formulation, and Characterization
  Jasmine Musakhanian, Gattefossé USA

• May 10, 2007
  A Pediatricians Perspective of Pharmacotherapeutic Trial Philosophy and Processes: Children as Subjects
  Dr. Andrew Mulberg, Mature Products Therapeutic Area

• April 8, 2007
  Making our Data Patterns Visible
  Dr. Anil Mennon, Sanofi-Aventis

• March 8, 2007
  A Pharma View of the CYPHER® Sirolimus-eluting Coronary Stent
  Dr. Cynthia Maryanoff, Cordis Corporation, J&J Company

• February 8, 2007
  Pseudolatex Coatings in Controlled Release
  Dr. Brian AC Carlin MRPharmS, MRSC CChem, FMC BioPolymer

• January 11, 2007
  Soluble Macromolecular Conjugates for Passive Tumor Targeting
  Dr. Clyde Ofner III, University of the Sciences in Philadelphia